Composition
- Active ingredients
- ROFECOXIB 25MG/5ML
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ROFECOXIB 50MG · TabletNDA021042-003 · Discontinued
- ROFECOXIB 12.5MG · TabletNDA021042-001 · Discontinued
- ROFECOXIB 25MG · TabletNDA021042-002 · Discontinued
- ROFECOXIB 50MG · TabletNDA021647-003 · Discontinued
- ROFECOXIB 12.5MG · TabletNDA021647-001 · Discontinued
- ROFECOXIB 25MG · TabletNDA021647-002 · Discontinued
- ROFECOXIB 25MG/5ML · SuspensionThis page
- ROFECOXIB 12.5MG/5ML · SuspensionNDA021052-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA021052.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Vioxx
- Active substance
- rofecoxib
- Route
- Oral
- Dosage form
- Suspension
- Applicant
- Merck
- Status
- Discontinued
- FDA approval
- 20 May 1999
- Application
- NDA021052-002